CD274 and neoplasm: Vitale and colleagues constructed an oncolytic AV carrying an anti-PD-L1 antibody expression cassette (Ad5Δ24-anti-PD-L1-scFv) and evaluated its anti-tumor effects in subcutaneous B16.OVA tumors.